Altarex Corporation

AltaRex Corp. is a biotechnology company focused on the research and development of foreign antibodies that activate the immune system for the treatment of various cancers. AltaRex is a development stage product company with a proprietary technology platform and key intellectual property.

Contact Details: 610 Lincoln Street Waltham MA 02451 United States of America Tel: 781 672 0138 Fax: 781 672 0142 Email: WWW: www.altarex.com/

Loading...

Recent Publications by Altarex Corporation:
Monitoring of immune responses to CA125 with an IFN-gamma ELISPOT assay. The CA125 (carcinoma antigen 125)-specific antibody MAb-B43.13 (OvaRex...	5th November, 2003	AltaRex Corporation,	J Immunol Methods. 2003 Aug;279(1-2):1-15.
Immunomodulation with antibodies: clinical application in ovarian cancer and other malignancies. This review identifies the role of antibodies in the field of therapeutic...	26th September, 2003	AltaRex	Expert Rev Vaccines. 2002 Jun;1(1):35-48. DOI Direct Link
Use of encapsulated single chain antibodies for induction of anti-idiotypic humoral and cellular immune responses. The use of biodegradable poly(lactic-co-glycolic acid) (PLGA) microspheres...	19th July, 2000	Research and Development, AltaRex Corp., 300, 8625-112 Street, Edmonton,	J Pharm Sci. 1998 Nov;87(11):1375-8. DOI Direct Link
Preparation and protein conjugation of a divinyl sulphone derivatized bifunctional chelating agent. A new bifunctional chelating agent with a novel linking arm, 2-[p-...	6th July, 2000	AltaRex Inc., Edmonton, Alberta, Canada.	Cancer Biother Radiopharm. 1996 Dec;11(6):405-14.

BioNews Results for Altarex Corporation:
Reagents and methods for inducing an immune response to prostate specific antigen	PharmCast:  Sep 8 2009 3:58AM Matching: altarex

Altarex Corporation Clinical Trials:
Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

Altarex Corporation Patents:
US Patent No.	Title
7579445	Reagents and methods for inducing an immune response to prostate specific antigen
7361346	Therapeutic compositions that produce an immune response
7318921	Therapeutic compositions that alter the immune response
7147850	Therapeutic binding agents against MUC-1 antigen and methods for their use
6881405	Reagents and methods for inducing an immune response to prostate specific antigen
→View more Altarex Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 593 times since April 2007, the link to the organisation's website has been followed 125 times

Recent Search Terms used to find this page: Altarex Corporation | AltaRex | altarex corporation | altarex corporation | altarex corporation | AltaRex | alta rex corporation | altarex corporation | altarex corp | alta rex medical | .

Search for more companies in Waltham

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Altarex Corporation